Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications
Yufeng Wei, Rameen Shah
Pharmaceuticals (2020) Vol. 13, Iss. 7, pp. 155-155
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Alcohol and other substance use during the COVID-19 pandemic: A systematic review
Amanda Roberts, Jim Rogers, Rachael Mason, et al.
Drug and Alcohol Dependence (2021) Vol. 229, pp. 109150-109150
Open Access | Times Cited: 330
The association between physical activity and mental health during the first year of the COVID-19 pandemic: a systematic review
Priscila Marconcin, André O. Werneck, Miguel Peralta, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 171
Social Networks Consumption and Addiction in College Students during the COVID-19 Pandemic: Educational Approach to Responsible Use
José Gómez Galán, José Ángel Martínez López, Cristina Lázaro-Pérez, et al.
Sustainability (2020) Vol. 12, Iss. 18, pp. 7737-7737
Open Access | Times Cited: 97
Neuroinflammation and Its Impact on the Pathogenesis of COVID-19
Mohammed M. Almutairi, Farzane Sivandzade, Thamer H. Albekairi, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 61
A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic
Wendy Wing-Yee Chong, Zeynep Ilgaz Acar, Meghan Lee West, et al.
Cannabis and Cannabinoid Research (2022) Vol. 7, Iss. 5, pp. 591-602
Open Access | Times Cited: 40
Tobacco use as a well-recognized cause of severe COVID-19 manifestations
A. Gupta, Suzanne Tanya Nethan, Ravi Mehrotra
Respiratory Medicine (2020) Vol. 176, pp. 106233-106233
Open Access | Times Cited: 61
Suicide during COVID-19 and other major international respiratory outbreaks: A systematic review
Karine Kahil, Mohamad Ali Cheaito, Rawad El Hayek, et al.
Asian Journal of Psychiatry (2020) Vol. 56, pp. 102509-102509
Open Access | Times Cited: 57
Substance use during COVID-19 pandemic: impact on the underserved communities
Natalia C. Chacon, Namrata Walia, Abigail A. Allen, et al.
Discoveries (2021) Vol. 9, Iss. 4, pp. e141-e141
Open Access | Times Cited: 51
Changing Patterns of Substance Use During the Coronavirus Pandemic: Self-Reported Use of Tobacco, Alcohol, Cannabis, and Other Drugs
Annemieke Benschop, Floor van Bakkum, Judith Noijen
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 49
‘They already operated like it was a crisis, because it always has been a crisis’: a qualitative exploration of the response of one homeless service in Scotland to the COVID-19 pandemic
Tessa Parkes, Hannah Carver, Wendy Masterton, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 45
Public policy for healthy living: How COVID-19 has changed the landscape
Laurie P. Whitsel, Funke Ajenikoko, Paul Chase, et al.
Progress in Cardiovascular Diseases (2023) Vol. 76, pp. 49-56
Open Access | Times Cited: 18
Psychometric properties and psychological correlates of the COVID‐19 Anxiety Syndrome Scale: A comprehensive systematic review and meta‐analysis
Mehdi Akbari, Mohammad Seydavi, Maryam Babaeifard, et al.
Clinical Psychology & Psychotherapy (2023) Vol. 30, Iss. 5, pp. 931-949
Closed Access | Times Cited: 14
High-throughput wastewater analysis for substance use assessment in central New York during the COVID-19 pandemic
Shiru Wang, Hyatt Green, Maxwell L. Wilder, et al.
Environmental Science Processes & Impacts (2020) Vol. 22, Iss. 11, pp. 2147-2161
Closed Access | Times Cited: 38
Substance use, mental disorders and COVID-19: a volatile mix
Christina Marel, Katherine L. Mills, Maree Teesson
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 4, pp. 351-356
Open Access | Times Cited: 30
Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data
Fares Qeadan, Benjamin Tingey, Rona Bern, et al.
EClinicalMedicine (2021) Vol. 37, pp. 100938-100938
Open Access | Times Cited: 27
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study
Caige Huang, Yue Wei, Vincent Ka Chun Yan, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 6, pp. 403-413
Open Access | Times Cited: 11
Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data
Tinghui Liu, Po‐Yu Huang, Jheng‐Yan Wu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Closed Access | Times Cited: 11
Chronic alcohol intake regulates expression of SARS‐CoV2 infection‐relevant genes in an organ‐specific manner
Marion M. Friske, Francesco Giannone, Mona Senger, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 1, pp. 76-86
Open Access | Times Cited: 10
Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study
Farihah Ali, Ashima Kaura, Cayley Russell, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain
Linda Francistiová, Adrián Klepe, Géza Curley, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
A narrative review of the use of alcohol during the Covid-19 pandemic; effects and implications
Maria Anna Bantounou
Journal of Addictive Diseases (2022) Vol. 41, Iss. 1, pp. 30-40
Open Access | Times Cited: 14
Liver injury in COVID-19: an insight into pathobiology and roles of risk factors
Abbas Tazarghi, Sahar Bazoq, M H Taziki, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Mental health conditions and COVID-19 vaccine outcomes: A scoping review
Ru Jia, Carol Coupland, Yana Vinogradova, et al.
Journal of Psychosomatic Research (2024) Vol. 183, pp. 111826-111826
Open Access | Times Cited: 2
Clinical impact of COVID-19 on people with substance use disorders
Gabriel Vallecillo, Rafael Perelló, Robert Güerri, et al.
Journal of Public Health (2020) Vol. 43, Iss. 1, pp. 9-12
Open Access | Times Cited: 21
Epidemiological and clinical risk factors related to severe COVID-19 in Iran: a multi-center study
Seyed Mohammad Hashemi‐Shahri, Seyed Mohammad Nasiraldin Tabatabaei, Alireza Ansari‐Moghaddam, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top